Reimbursement list changes announced by Health Ministry

…hypercholesterolemia with alirocumab. The number of drug programmes has doubled since 2012, from 72 to 140, the number of eligible patients has almost tripled from 47,000 to 135,000, and the annual budget for drug programmes has risen from PLN 2bn (€466m) to over PLN 3bn (€699m). »

Affidea opens diagnostic imaging centre in a shopping mall

…MRI scans using a 1.5T system and CT exams using a 64-slice system. It also offers specialist consultations and laboratory tests.   Galeria Metropolia is Affidea’s second diagnostic imaging centre in Gdansk. The company has around 30 centres in nine voivodships in Poland. »

ZAPPA: DOZ should dispose of 413 pharmacies if government is serious about enforcing anti-concentration laws

…the marketplace, proper enforcement of the anti-concentration laws and the advertising ban; and pharmacies as an integral part of the healthcare system, providers of pharmaceutical care to patients, rather than “medication supermarkets bent on maximising sales and profits”.   »

Number of active ingredients reimbused via drug programmes increased by 40% since 2015

…by 40% during this period, according to figures published by the Health Ministry on 15 October. A total of 4,319 drugs are now included on the pharmacy list, up from 3,877 in 2015; and 140 active ingredients are reimbursed via drug programmes, up from 100 in 2015, the data show. »

Regulatory changes hurt pharmacy sales of dermocosmetics

Monika Stefańczyk,
Head Pharmaceutical Analyst, PMR

Sales of dermocosmetics in Poland’s pharmacies will grow in value at an average rate of about 3% per annum in the period 2019-2023, a new report from PMR predicts. The other two channels of dermocosmetics retail – non-pharmacy and online – are expected to witness quicker… »

Grupa Scanmed modernises Czestochowa hospital

…or hip replacements. As the next step, Scanmed will modernise the gynaecology, obstetrics and neonatology ward, to be followed by paediatrics. Grupa Scanmed has over 40 sites across the country, including a number of hospitals and a network of interventional cardiology centres. »

S-list drug sales represent 9% of total Rx sales in phamacies

…from the S-list prescribed to seniors are not dispensed free of charge – patients still have to co-pay. This happens in around 9% of all cases – either because the prescriber is not the patient’s own GP, or the therapeutic indication is not included on the S-list.   »

Polpharma signs cross-licensing partnership with Italian ophthalmic therapies maker

…ophthalmic care company. It designs, manufactures and markets innovative pharmaceutical specialty products, nutraceuticals, surgical and medical devices. Headquartered in Catania, Sicily, it operates directly in Italy, France, Spain, Romania and Mexico and employs over 370 people worldwide. »

Modern psychiatric hospital opens near Warsaw

…of Technology; and it will also focus on prophylactics and mental health promotion, said Norbert Szczepanski, Board Member. The new complex was built with the help of a PLN 95m (€22m) grant from the Regional Operational Programme of the Mazowieckie Voivodship for 2014-2020.   »

Polmed’s owners buy out minority interests

…Magdon, and several related entities launched a joint bid for the 46.5% of shares and 38.1% of voting rights in the company that they did not already own, and managed to buy almost all of them by August. Founded in 1999, Polmed floated its shares on the WSE in 2010. Polmed has 22 clinics. »